| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Multi Organ Transplant Program, Toronto General Hospital and University of Toronto, Toronto, Ontario, Canada;
Department of Pathology, Texas A&M University, College Station, TX 77843; and
McMaster University, Hamilton, Ontario, Canada
fgl2 prothrombinase, by its ability to generate thrombin, has been shown to be pivotal to the pathogenesis of viral-induced hepatitis, cytokine-induced fetal loss syndrome, and xeno- and allograft rejection. In this study, the molecular basis of fgl2 prothrombinase activity was examined in detail. Purified fgl2 protein generated in a baculovirus expression system had no measurable prothrombinase activity, whereas the activity was restored when the purified protein was reconstituted into phosphatidyl-L-serine-containing vesicles. Reconstituted fgl2 catalyzed the cleavage of human prothrombin to thrombin with kinetics consistent with a first order reaction, with an apparent Vmax value of 6 mol/min/mol fgl2 and an apparent Km value for prothrombin of 8.3 µM. The catalytic activity was totally dependent on calcium, and factor Va (500 nM) enhanced the catalytic efficiency of fgl2 by increasing the apparent Vmax value to 3670 mol/min/mol fgl2 and decreasing the apparent Km value for prothrombin to 7.2 µM. By a combination of site-directed mutagenesis and production of truncated proteins, it was clearly shown that residue Ser89 was critical for the prothrombinase activity of fgl2. Furthermore, fgl2 prothrombinase activity was not inhibited by antithrombin III, soybean trypsin inhibitor, 4-aminobenzamidine, aprotinin, or phenylmethylsulfonyl fluoride, whereas diisopropylfluorophosphate completely abrogated the activity. In this work we provide direct evidence that fgl2 cleaves prothrombin to thrombin consistent with serine protease activity and requires calcium, phospholipids, and factor Va for its full activity.
This article has been cited by other articles:
|
|
 |
|
  J. Mu, D. Qu, A. Bartczak, M. J. Phillips, J. Manuel, W. He, C. Koscik, M. Mendicino, L. Zhang, D. A. Clark, et al. Fgl2 deficiency causes neonatal death and cardiac dysfunction during embryonic and postnatal development in mice Physiol Genomics, September 11, 2007; 31(1): 53 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Phillippe, D. F. Bradley, K. Phillippe, and D. Engle Tissue Prothrombinase Activity in Myometrium From Timed-Pregnant Rats Reproductive Sciences, October 1, 2006; 13(7): 477 - 482. [Abstract] [PDF]
|
|
|
|
|
|
M. Phillippe, D. F. Bradley, H. Ji, K. H. Oppenheimer, and E. K. Chien Phospholipid Scramblase Isoform Expression in Pregnant Rat Uterus Reproductive Sciences, October 1, 2006; 13(7): 497 - 501. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Mendicino, M. Liu, A. Ghanekar, W. He, C. Koscik, I. Shalev, M. Javadi, J. Turnbull, W. Chen, L. Fung, et al. Targeted Deletion of Fgl-2/Fibroleukin in the Donor Modulates Immunologic Response and Acute Vascular Rejection in Cardiac Xenografts Circulation, July 12, 2005; 112(2): 248 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Olson, V. P. Winfrey, S. K. NagDas, and M. H. Melner Region-specific Expression and Secretion of the Fibrinogen-related Protein, fgl2, by Epithelial Cells of the Hamster Epididymis and Its Role in Disposal of Defective Spermatozoa J. Biol. Chem., December 3, 2004; 279(49): 51266 - 51274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ghanekar, M. Mendicino, H. Liu, W. He, M. Liu, R. Zhong, M. J. Phillips, G. A. Levy, and D. R. Grant Endothelial Induction of fgl2 Contributes to Thrombosis during Acute Vascular Xenograft Rejection J. Immunol., May 1, 2004; 172(9): 5693 - 5701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. W. Hancock, F. M. Szaba, K. N. Berggren, M. A. Parent, I. K. Mullarky, J. Pearl, A. M. Cooper, K. H. Ely, D. L. Woodland, I.-J. Kim, et al. Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN{gamma}-inducible fibrinogen-like protein 2 PNAS, March 2, 2004; 101(9): 3005 - 3010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Clark, K. Foerster, L. Fung, W. He, L. Lee, M. Mendicino, U. R. Markert, R. M. Gorczynski, P. A. Marsden, and G. A. Levy The fgl2 prothrombinase/fibroleukin gene is required for lipopolysaccharide-triggered abortions and for normal mouse reproduction Mol. Hum. Reprod., February 1, 2004; 10(2): 99 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhao, K. E. Pearson, D. A. Stephan, and P. Russell Effects of Prostaglandin Analogues on Human Ciliary Muscle and Trabecular Meshwork Cells Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 1945 - 1952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. Y. Chan, L. S. Kay, R. G. Khadaroo, M. W. C. Chan, S. Lakatoo, K. J. Young, L. Zhang, R. M. Gorczynski, M. Cattral, O. Rotstein, et al. Soluble Fibrinogen-Like Protein 2/Fibroleukin Exhibits Immunosuppressive Properties: Suppressing T Cell Proliferation and Inhibiting Maturation of Bone Marrow-Derived Dendritic Cells J. Immunol., April 15, 2003; 170(8): 4036 - 4044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. F. Rychlik, E. K. Chien, D. Wolff, S. Phillippe, and M. Phillippe Cloning and Tissue expression of the Tissue Prothrombinase Fgl-2 in the Sprague-Dawley Rat Reproductive Sciences, February 1, 2003; 10(2): 67 - 73. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
